Meningococcal Vaccine Market Report

Europe Meningococcal Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Dec 24, 2019
  • PAGES：141
  • REPORT CODE：GMM409551
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Meningococcal Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Meningococcal Vaccine Market Segmentations:

    By Player:

    • Merck

    • Bio-Med

    • CSL

    • Hualan Bio

    • China National Biotec Group

    • Baxter

    • Walvax

    • Serum Institute of India

    • GSK

    • Novartis

    • Zhifei

    • JN International Medical Corporation

    By Type:

    • Quadrivalent

    • Bivalent

    • Others

    By End-User:

    • Pneumonia

    • Meningitis

    • Bacteremia

    • Others (Arthritis, Conjunctivitis, Urethritis)

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Meningococcal Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Meningococcal Vaccine Market Size and Growth Rate of Quadrivalent from 2014 to 2026

    • 1.3.2 Europe Meningococcal Vaccine Market Size and Growth Rate of Bivalent from 2014 to 2026

    • 1.3.3 Europe Meningococcal Vaccine Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Meningococcal Vaccine Market Size and Growth Rate of Pneumonia from 2014 to 2026

    • 1.4.2 Europe Meningococcal Vaccine Market Size and Growth Rate of Meningitis from 2014 to 2026

    • 1.4.3 Europe Meningococcal Vaccine Market Size and Growth Rate of Bacteremia from 2014 to 2026

    • 1.4.4 Europe Meningococcal Vaccine Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis) from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Meningococcal Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Meningococcal Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Quadrivalent

      • 3.4.2 Market Size and Growth Rate of Bivalent

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Meningococcal Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Meningococcal Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Meningococcal Vaccine for Pneumonia

      • 4.4.2 Market Size and Growth Rate of Meningococcal Vaccine for Meningitis

      • 4.4.3 Market Size and Growth Rate of Meningococcal Vaccine for Bacteremia

      • 4.4.4 Market Size and Growth Rate of Meningococcal Vaccine for Others (Arthritis, Conjunctivitis, Urethritis)

    5 Market Analysis by Major Regions

    • 5.1 Europe Meningococcal Vaccine Production Analysis by Top Regions

    • 5.2 Europe Meningococcal Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Meningococcal Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Meningococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Meningococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Meningococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Meningococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Meningococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Meningococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Meningococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Meningococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Meningococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Meningococcal Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Meningococcal Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Meningococcal Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Meningococcal Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Meningococcal Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Meningococcal Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Meningococcal Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Meningococcal Vaccine Landscape Analysis

    • 7.1 Germany Meningococcal Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Meningococcal Vaccine Landscape Analysis by Major End-Users

    8. UK Meningococcal Vaccine Landscape Analysis

    • 8.1 UK Meningococcal Vaccine Landscape Analysis by Major Types

    • 8.2 UK Meningococcal Vaccine Landscape Analysis by Major End-Users

    9. France Meningococcal Vaccine Landscape Analysis

    • 9.1 France Meningococcal Vaccine Landscape Analysis by Major Types

    • 9.2 France Meningococcal Vaccine Landscape Analysis by Major End-Users

    10. Italy Meningococcal Vaccine Landscape Analysis

    • 10.1 Italy Meningococcal Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Meningococcal Vaccine Landscape Analysis by Major End-Users

    11. Spain Meningococcal Vaccine Landscape Analysis

    • 11.1 Spain Meningococcal Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Meningococcal Vaccine Landscape Analysis by Major End-Users

    12. Poland Meningococcal Vaccine Landscape Analysis

    • 12.1 Poland Meningococcal Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Meningococcal Vaccine Landscape Analysis by Major End-Users

    13. Russia Meningococcal Vaccine Landscape Analysis

    • 13.1 Russia Meningococcal Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Meningococcal Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Meningococcal Vaccine Landscape Analysis

    • 14.1 Switzerland Meningococcal Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Meningococcal Vaccine Landscape Analysis by Major End-Users

    15. Turkey Meningococcal Vaccine Landscape Analysis

    • 15.1 Turkey Meningococcal Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Meningococcal Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Meningococcal Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Meningococcal Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Meningococcal Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Meningococcal Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Meningococcal Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Meningococcal Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Meningococcal Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Meningococcal Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Meningococcal Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Meningococcal Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Meningococcal Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Merck

      • 19.1.1 Merck Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Bio-Med

      • 19.2.1 Bio-Med Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 CSL

      • 19.3.1 CSL Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Hualan Bio

      • 19.4.1 Hualan Bio Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 China National Biotec Group

      • 19.5.1 China National Biotec Group Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Baxter

      • 19.6.1 Baxter Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Walvax

      • 19.7.1 Walvax Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Serum Institute of India

      • 19.8.1 Serum Institute of India Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 GSK

      • 19.9.1 GSK Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Novartis

      • 19.10.1 Novartis Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Zhifei

      • 19.11.1 Zhifei Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 JN International Medical Corporation

      • 19.12.1 JN International Medical Corporation Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 97 Figures and 119 Tables)

    • Figure Product Picture

    • Figure Europe Meningococcal Vaccine Market Size and Growth Rate of Quadrivalent from 2014 to 2026

    • Figure Europe Meningococcal Vaccine Market Size and Growth Rate of Bivalent from 2014 to 2026

    • Figure Europe Meningococcal Vaccine Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Meningococcal Vaccine Market Size and Growth Rate of Pneumonia from 2014 to 2026

    • Figure Europe Meningococcal Vaccine Market Size and Growth Rate of Meningitis from 2014 to 2026

    • Figure Europe Meningococcal Vaccine Market Size and Growth Rate of Bacteremia from 2014 to 2026

    • Figure Europe Meningococcal Vaccine Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis) from 2014 to 2026

    • Figure Germany Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Meningococcal Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Meningococcal Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Meningococcal Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Meningococcal Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Quadrivalent

    • Figure Market Size and Growth Rate of Bivalent

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Meningococcal Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Meningococcal Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Pneumonia

    • Figure Market Size and Growth Rate of Meningitis

    • Figure Market Size and Growth Rate of Bacteremia

    • Figure Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis)

    • Table Europe Meningococcal Vaccine Production by Major Regions

    • Table Europe Meningococcal Vaccine Production Share by Major Regions

    • Figure Europe Meningococcal Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Meningococcal Vaccine Consumption by Major Regions

    • Table Europe Meningococcal Vaccine Consumption Share by Major Regions

    • Table Germany Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table France Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Meningococcal Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Meningococcal Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Meningococcal Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Meningococcal Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table UK Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table France Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Bio-Med

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Med

    • Figure Sales and Growth Rate Analysis of Bio-Med

    • Figure Revenue and Market Share Analysis of Bio-Med

    • Table Product and Service Introduction of Bio-Med

    • Table Company Profile and Development Status of CSL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

    • Figure Sales and Growth Rate Analysis of CSL

    • Figure Revenue and Market Share Analysis of CSL

    • Table Product and Service Introduction of CSL

    • Table Company Profile and Development Status of Hualan Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Bio

    • Figure Sales and Growth Rate Analysis of Hualan Bio

    • Figure Revenue and Market Share Analysis of Hualan Bio

    • Table Product and Service Introduction of Hualan Bio

    • Table Company Profile and Development Status of China National Biotec Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China National Biotec Group

    • Figure Sales and Growth Rate Analysis of China National Biotec Group

    • Figure Revenue and Market Share Analysis of China National Biotec Group

    • Table Product and Service Introduction of China National Biotec Group

    • Table Company Profile and Development Status of Baxter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter

    • Figure Sales and Growth Rate Analysis of Baxter

    • Figure Revenue and Market Share Analysis of Baxter

    • Table Product and Service Introduction of Baxter

    • Table Company Profile and Development Status of Walvax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Walvax

    • Figure Sales and Growth Rate Analysis of Walvax

    • Figure Revenue and Market Share Analysis of Walvax

    • Table Product and Service Introduction of Walvax

    • Table Company Profile and Development Status of Serum Institute of India

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India

    • Figure Sales and Growth Rate Analysis of Serum Institute of India

    • Figure Revenue and Market Share Analysis of Serum Institute of India

    • Table Product and Service Introduction of Serum Institute of India

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Zhifei

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zhifei

    • Figure Sales and Growth Rate Analysis of Zhifei

    • Figure Revenue and Market Share Analysis of Zhifei

    • Table Product and Service Introduction of Zhifei

    • Table Company Profile and Development Status of JN International Medical Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JN International Medical Corporation

    • Figure Sales and Growth Rate Analysis of JN International Medical Corporation

    • Figure Revenue and Market Share Analysis of JN International Medical Corporation

    • Table Product and Service Introduction of JN International Medical Corporation

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US